OClawVPS.com
Intelligent OMICS Ltd
Edit

Intelligent OMICS Ltd

https://www.intellomx.com/
Last activity: 28.04.2025
Active
Categories: AnalyticsDataDiagnosticsDrugHouseMedTechOwnResearchTechnologyTools
Intelligent OMICS Ltd (Intellomx) is a UK-based AI company that discovers new drugs. We use proprietary technology to identify the biological targets that research has missed and we then progress drug development from idea to IND. ​ We collaborate with others via fee-for-service projects but we also practice what we preach, applying our own technology in-house. We currently seek partners for our lung cancer/KRAS drugs, identified using our own technology. Contact us if we can help you discover drugs for your pipeline too. ​ Technology: Our systems approach is called "Intuitive Informed Intelligence". Our technology approach is based on high speed creation of Artificial Neural Networks (ANNs) which can evaluate tens of millions of data in short period of time, to identity key drivers for systems biology. And to connect these drives to therapeutic modalities including new drugs, repurposed drugs and biomarker panels for disease. ​ Intellomx uses novel proprietary Artificial Intelligence approaches applied to translational biology to discover new drugs for old diseases identify existing drugs for new targets create new diagnostics to stratify patient populations ​ We transform biological data into clinical benefit! Come join the AI-driven drug discovery revolution.
Followers
256
Mentions
3
Location: United Kingdom, England, Nottingham
Employees: 1-10
Founded date: 2009

Investors 1

DateNameWebsite
-BioCitybiocity.co...

Mentions in press and media 3

DateTitleDescription
28.04.2025Intellomx Launches Swarm-Based AI Platform to Accelerate and De-Risk Novel Target and Drug DiscoveryIntellomx Corporate Logo Prof Graham Ball, CSO of Intellomx Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic target identification capability. Intellomx now offers an e...
10.08.2023AI Drug Discovery Pioneer Intellomx Joins Johnson & Johnson Innovation (JLABS)Intellomx Corporate Logo Intellomx is pleased to announce that it has joined Johnson & Johnson Innovation (JLABS), a premier life science incubator program. We are excited to join the JLABS community and look forward to collaborating wi...
20.12.2022Intellomx Receives Coveted Approval in China for its Novel Diagnostic Study on Detection of Latent LuberculosisIntellomx Corporate Logo Xianxiang Chen, Chairman of Wuhan Pulmonary Hospital Photo of Simon Haworth, Director of Intellomx Intellomx have received Chinese government approval for a novel clinical diagnostics study for TB, to distinguish pa...

Reviews 0

Sign up to leave a review

Sign up Log In